Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Fireside chats

<< Previous

Bullboard Posts

Next >>

Comment by StockingUp21on Jun 16, 2021 7:21am

205 Views

Post# 33394091

RE:RE:RE:RE:RE:RE:Fireside chats

3 years and nothing. But lots of gift shares, dilution and insiderselling

MasterAlgae wrote: Summer officially starts in a week... My question would be in the morning or the afternoon? I wish that "dates" were not so amorphous and breezy/vernacular. Feet to the fire. This isn't a non-profit organization, although it is...

On July 16th 2019, Antibe reported that the company "was now engaging multinational pharmaceutical firms with a goal of securing strategic partnerships for the large markets."

They reported that they were working on statins in the same report anything on that?

Fotoforester wrote:
Ah I see. I personally seem to recall him saying that he won't look at it until summer. Some transparency would definitely be nice, I can agree with that.